Patient-reported outcomes in relapsing forms of MS: Real-world, global treatment experience with teriflunomide from the Teri-PRO study
Keywords: AEs; adverse events; ALT; alanine aminotransferase; BL; baseline; CI; confidence interval; DMF; dimethyl fumarate; DMTs; disease-modifying therapies; EDSS; Expanded Disability Status Scale; ES; effect size; MedDRA; Medical Dictionary for Regulatory Activi